260 related articles for article (PubMed ID: 8231204)
1. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass.
Tabuchi N; de Haan J; Boonstra PW; van Oeveren W
J Thorac Cardiovasc Surg; 1993 Nov; 106(5):828-33. PubMed ID: 8231204
[TBL] [Abstract][Full Text] [Related]
2. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.
Nakajima T; Osawa S; Ogawa M; Sasaki T; Izumoto H; Yagi Y; Kawazoe K
ASAIO J; 1996; 42(4):301-5. PubMed ID: 8828788
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass.
Philippou H; Adami A; Davidson SJ; Pepper JR; Burman JF; Lane DA
Thromb Haemost; 2000 Jul; 84(1):124-8. PubMed ID: 10928482
[TBL] [Abstract][Full Text] [Related]
4. Comparison of blood activation in the wound, active vent, and cardiopulmonary bypass circuit.
Fabre O; Vincentelli A; Corseaux D; Juthier F; Susen S; Bauters A; Van Belle E; Mouquet F; Le Tourneau T; Decoene C; Crépin F; Prat A; Jude B
Ann Thorac Surg; 2008 Aug; 86(2):537-41. PubMed ID: 18640330
[TBL] [Abstract][Full Text] [Related]
5. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
[TBL] [Abstract][Full Text] [Related]
6. Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass.
de Haan J; Schönberger J; Haan J; van Oeveren W; Eijgelaar A
J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1017-23. PubMed ID: 8246533
[TBL] [Abstract][Full Text] [Related]
7. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients.
Lindholm L; Westerberg M; Bengtsson A; Ekroth R; Jensen E; Jeppsson A
Ann Thorac Surg; 2004 Dec; 78(6):2131-8; discussion 2138. PubMed ID: 15561050
[TBL] [Abstract][Full Text] [Related]
8. Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting.
Nakahira A; Sasaki Y; Hirai H; Fukui T; Matsuo M; Takahashi Y; Kotani S; Suehiro S
Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):555-60. PubMed ID: 20061337
[TBL] [Abstract][Full Text] [Related]
9. Changes in pericardial morphology and fibrinolytic activity during cardiopulmonary bypass.
Nkere UU; Whawell SA; Thompson EM; Thompson JN; Taylor KM
J Thorac Cardiovasc Surg; 1993 Aug; 106(2):339-45. PubMed ID: 8341074
[TBL] [Abstract][Full Text] [Related]
10. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
[TBL] [Abstract][Full Text] [Related]
11. Activation of fibrinolysis in the pericardial cavity after cardiopulmonary bypass.
Khalil PN; Ismail M; Kalmar P; von Knobelsdorff G; Marx G
Thromb Haemost; 2004 Sep; 92(3):568-74. PubMed ID: 15351853
[TBL] [Abstract][Full Text] [Related]
12. Enhanced effective fibrinolysis following the neutralization of heparin in open heart surgery increases the risk of post-surgical bleeding.
Gram J; Janetzko T; Jespersen J; Bruhn HD
Thromb Haemost; 1990 Apr; 63(2):241-5. PubMed ID: 2114043
[TBL] [Abstract][Full Text] [Related]
13. The impact of cardiac ischemia and reperfusion on markers of activated haemostasis and fibrinolysis during cardiopulmonary bypass: comparison of plasma levels in arterial and coronary venous blood.
Kalweit G; Bach J; Huwer H; Winning J; Hellstern P
Thromb Res; 2005; 116(1):33-9. PubMed ID: 15850606
[TBL] [Abstract][Full Text] [Related]
14. Activation of the hemostatic system during cardiopulmonary bypass.
Sniecinski RM; Chandler WL
Anesth Analg; 2011 Dec; 113(6):1319-33. PubMed ID: 22003219
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
Despotis GJ; Joist JH
J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
[TBL] [Abstract][Full Text] [Related]
16. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass.
Chan AK; Leaker M; Burrows FA; Williams WG; Gruenwald CE; Whyte L; Adams M; Brooker LA; Adams H; Mitchell L; Andrew M
Thromb Haemost; 1997 Feb; 77(2):270-7. PubMed ID: 9157580
[TBL] [Abstract][Full Text] [Related]
17. Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system.
Jensen E; Andréasson S; Bengtsson A; Berggren H; Ekroth R; Larsson LE; Ouchterlony J
Ann Thorac Surg; 2004 Mar; 77(3):962-7. PubMed ID: 14992907
[TBL] [Abstract][Full Text] [Related]
18. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
[TBL] [Abstract][Full Text] [Related]
19. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
Dietrich W; Mössinger H; Spannagl M; Jochum M; Wendt P; Barankay A; Meisner H; Richter JA
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):712-20. PubMed ID: 7682267
[TBL] [Abstract][Full Text] [Related]
20. Quantitative and temporal differences in coagulation, fibrinolysis and platelet activation after on-pump and off-pump coronary artery bypass surgery.
Vallely MP; Bannon PG; Bayfield MS; Hughes CF; Kritharides L
Heart Lung Circ; 2009 Apr; 18(2):123-30. PubMed ID: 19081297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
